Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00784394 · ClinicalTrials.gov registry record · Phase 1
Diindolylmethane in Preventing Cancer in Healthy Volunteers
A Phase 1 study, sponsored by National Cancer Institute (NCI).
- Completed
- Registry status
- Phase 1
- Development phase
- 20
- Enrollment target
NCT00784394: Completed Phase 1 study, sponsored by National Cancer Institute (NCI).
NCT00784394 is a Phase 1 study that has completed, run by National Cancer Institute (NCI). The registered enrollment target is 20 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00784394, a Phase 1 study, has completed, sponsored by National Cancer Institute (NCI).
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 20 participants
- Enrollment target
Study Summary
This phase I clinical trial studies the side effects and best dose of diindolylmethane in preventing cancer in healthy volunteers. Diindolylmethane is formed in the stomachs of people who eat a chemical that is normally found in vegetables, including cabbage, broccoli, Brussels sprouts, cauliflower, and watercress. Diindolylmethane may prevent the development of cancer.
Interventions
- OTHER laboratory biomarker analysis
- OTHER placebo
- OTHER quality-of-life assessment
- OTHER pharmacological study
- DRUG diindolylmethane
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2004-04 |
| Est. Completion | 2009-10 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00784394
The ClinicalTrials.gov registry entry for NCT00784394 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Cancer Institute (NCI), which has 3,257 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which laboratory biomarker analysis is the first listed.
NCT00784394 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00784394 about?
NCT00784394 is a clinical study titled "Diindolylmethane in Preventing Cancer in Healthy Volunteers". This phase I clinical trial studies the side effects and best dose of diindolylmethane in preventing cancer in healthy volunteers. Diindolylmethane is formed in the stomachs of people who eat a chemical that is normally found in vegetables, including cabbage, broccoli, Brussels sprouts, cauliflower,...
What is the current status of trial NCT00784394?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 20 participants. The study started on 2004-04. Estimated completion is 2009-10.
What interventions are being tested in trial NCT00784394?
The interventions under investigation include: laboratory biomarker analysis (OTHER), placebo (OTHER), quality-of-life assessment (OTHER), pharmacological study (OTHER), diindolylmethane (DRUG).
Who is sponsoring clinical trial NCT00784394?
This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.